Vanguard Portfolio Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54B Buy
7,913,661
+49,739
+0.6% +$10.3M 0.07% 311
2026
Q1
$1.77B Buy
+7,863,922
New +$1.96B 0.09% 249

Other funds holding RMD

Vanguard Portfolio Management's RMD Position: Q2 2026 in Review

Vanguard Portfolio Management increased its ResMed (RMD) stake by 0.63% in Q2 2026, buying an estimated $10.3M and bringing the position to 7,913,661 shares worth $1.54B. The position accounts for 0.07% of the portfolio, ranked #311.

Vanguard Portfolio Management first reported a position in RMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.77B in Q1 2026. 836 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Vanguard Portfolio Management held 7,913,661 shares of ResMed worth $1.54B as of Q2 2026.
  • Vanguard Portfolio Management bought 49,739 ResMed shares in Q2 2026, an estimated $10.3M.
  • ResMed made up 0.07% of Vanguard Portfolio Management's portfolio in Q2 2026, its #311 holding.
  • Vanguard Portfolio Management first reported a position in ResMed in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's ResMed position peaked at $1.77B in Q1 2026.
  • 836 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.